Purchase Order N3239821P0200
Award Date 5/3/21
Potential Completion Date 6/2/21
Potential Value $248K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Frederick, MD 21702, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the purchase of a LightCycler instrument by the Department of the Navy Bureau of Medicine and Surgery. The contract was awarded to the prime contractor, Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The contract is a firm fixed price purchase order with a potential value of $248,190.00 and a completion date of October 17, 2020. Roche Diagnostics is a foreign-owned, for-profit manufacturer and distributor of in vitro diagnostics,...
- This federal contract award is to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award, valued at $147,944.00, is a firm fixed price purchase order from the Department of the Navy Bureau of Medicine and Surgery. The award provides for the delivery of two specific medical diagnostic products - Light Cycler Uracil-NDA Glycosylase and a Kit...
- This contract award to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, is for the delivery of LIGHTCYLER URACIL-DNA glycosylase and DNTP BLEND products to the Department of the Navy Bureau of Medicine and Surgery. The $248,190.00 firm fixed price purchase order was awarded on July 20, 2021 with a completion date of August 6, 2021. No set-aside was used for this award. Roche Diagnostics is an established federal contractor, holding multiple General Services...
- The U.S. Navy's Bureau of Medicine and Surgery awarded a $1.0 million firm fixed-price delivery order to Roche Diagnostics Corporation on September 29, 2023, with an ultimate completion date of September 30, 2024. This child delivery order, which carries no set-aside designation, reflects open competition and is performed at Roche's facility in Castleton, Indiana. Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis, specializes in in vitro diagnostics,...
- This is a $787,038.78 firm fixed-price delivery order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical products. The contract, which has no set-aside designation, provides for the delivery of Roche's medical diagnostic technologies, including laboratory equipment, testing systems, reagents, and clinical testing services, to support...
- The U.S. Department of the Navy Bureau of Medicine and Surgery awarded a $131,758.96 firm-fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The award is for numerous antibodies in various quantities for the Ventana Benchmark System used in NMCSD laboratories. This award does not have a set-aside designation and was made on a sole-source basis due to only one source being able to meet...
- This federal contract award is for molecular testing equipment, with a ceiling value of $247,811.23. The contract was awarded to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments, on July 11, 2025. The contract is a Blanket Purchase Agreement (BPA) Call with a firm fixed price pricing type. The funding agency is the Defense Health Agency, a defense agency. The contract does not have a set-aside designation,...
- This federal contract award was made by the Department of the Navy Bureau of Medicine and Surgery to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for a COBAS ROCHE CPRR BRIDGE delivery order with a potential value of $359,732.49. The contract is firm-fixed price and does not have a set-aside designation. The contract is funded through Roche's existing General Services...
- This federal contract award was made by the Defense Health Agency to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $887,473.92 firm fixed-price delivery order was placed against Roche's General Services Administration (GSA) Schedule contract for Critical Analyzers, Laboratory (FSS-66-III). It does not have a set-aside...
- The Department of the Navy Bureau of Medicine and Surgery awarded a firm-fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer, to provide LightCycler Uracil-DNA Glycosylase products. The $147,918.00 contract has a completion date of October 15, 2019 and did not utilize a set-aside designation. Roche Diagnostics, also known as Roche Diagnostics Corp, has held multiple federal contracts to supply medical equipment, reagents, and testing services...